Delivery Order SPE2DR25D1053-SPE2DR26FT952
- Not listed
- The Defense Logistics Agency awarded a $134,778.88 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents, with an ultimate completion date of August 12, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,846.51 for Varivax vaccine with diluents on September 8, 2025, with an ultimate completion date of September 29, 2025. This is a firm fixed price, non-competitive delivery order with performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with DLA, leveraging the company's extensive capabilities as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VARIVAX vaccine with diluents on August 12, 2025, with a ceiling value of $1,032.11 and an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The work...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Varivax vaccine with diluents valued at $10,321.10 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain on June 30, 2025. The contract is set to complete by July 22, 2025, and represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on November 7, 2025, with a ceiling value of $1,998.92 and an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents under a firm fixed price contract valued at $1,053.01. This non-competitive delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,255.36 to supply Varivax vaccine with diluents. The contract, awarded on October 21, 2025, represents a firm fixed price delivery order with an ultimate completion date of November 12, 2025. This award was made on a competitive basis with no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on July 22, 2025, with a ceiling value of $5,160.55 and an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The vaccine delivery will...
- The Defense Logistics Agency awarded a $2,106.02 delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on September 3, 2025, with an ultimate completion date of September 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT952Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Varivax vaccine with diluents, valued at $4,997.30 with a firm fixed price structure. The contract is non-competitive and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of medical products to military and veteran healthcare systems through its DLA contracts. The Varivax delivery order supports the Defense Health Agency and other government healthcare systems' vaccine procurement requirements. This award demonstrates the company's continued role as a primary pharmaceutical supplier within DLA's global medical supply chain, fulfilling routine vaccine distribution needs essential to military personnel health readiness and immunization programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/17/25 |